Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher J. Coughlin currently holds 14,156.93 shares of ALEXION PHARMACEUTICALS, INC. (ALXN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher J. Coughlin has been a net buyer of ALXN stock. They have purchased $6.3M and sold $3.0M worth of shares.
Christopher J. Coughlin's most recent insider trade was on Mar 31, 2026, when they sold 1,140 shares at $0.00 per share.
Christopher J. Coughlin serves as Executive at ALEXION PHARMACEUTICALS, INC. (ALXN). They have executed 219 insider transactions totaling $9.3M over their tenure at the company.
Christopher J. Coughlin holds the position of Executive at ALEXION PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Christopher J. Coughlin has shown a buying trading pattern, with $6.3M in total purchases and $3.0M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Christopher J. Coughlin was on Mar 18, 2024, when they sold $6.1M worth of KRTX shares. This transaction involved 25,000 shares at $243.35 per share.
Christopher J. Coughlin currently owns 14,156.93 shares of ALEXION PHARMACEUTICALS, INC. (ALXN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher J. Coughlin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher J. Coughlin has 219 Form 4 filings on record as an insider at ALEXION PHARMACEUTICALS, INC..
Set alerts for Christopher J. Coughlin and 40,000+ other insiders.